Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 5.28% is 32% below its 5-year average of 7.78%, near the low end of its 5-year range (4.72%–13.71%).
As of the fiscal period ended Tuesday, June 30, 2026. 7.37% below its 12-month average of 5.70%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.28%.
DEBT TO ASSETS RATIO
5.28%
DEBT TO ASSETS RATIO AVG TTM
5.70%
DEBT TO ASSETS RATIO AVG 3Y
8.16%
DEBT TO ASSETS RATIO AVG 5Y
7.78%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-7.37%
CURRENT VS 3Y AVG
-35.22%
CURRENT VS 5Y AVG
-32.07%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 455 covered companies
CURRENT VS SECTOR MEDIAN
+4702.65%
vs the sector median at left
Aligos Therapeutics, Inc.
Market Cap
$33.42M
Debt to Assets Ratio
5.28%
TTM Avg
5.70%
3Y Avg
8.16%
5Y Avg
7.78%
Market Cap
$33.52M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$32.31M
Debt to Assets Ratio
1.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$31.36M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.89M
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$30.92M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | $33.42M | 5.28% | 5.70% | 8.16% | 7.78% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | 0.00% | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $32.32M | 0.01% | N/A | N/A | N/A |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | 1.40% | N/A | N/A | N/A |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | 0.19% | N/A | N/A | N/A |
| Accuray Incorporated (ARAY)vs › | $35.89M | 0.41% | N/A | N/A | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | 0.01% | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $36.05M | 0.14% | N/A | N/A | N/A |
| CervoMed Inc. (CRVO)vs › | $30.65M | 0.00% | N/A | N/A | N/A |
| HeartBeam, Inc. (BEAT)vs › | $36.31M | 0.00% | N/A | N/A | N/A |
Debt/Assets
5.3%
Debt/Equity
0.11
Current Ratio
2.19
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 5.28% |
| 2026-03-31 | 6.74% |
| 2025-12-31 | 5.86% |
| 2025-09-30 | 5.53% |
| 2025-06-30 | 5.11% |
| 2025-03-31 | 5.22% |
| 2024-12-31 | 11.95% |
| 2024-09-30 | 10.33% |
| 2024-06-30 | 9.04% |
| 2024-03-31 | 8.20% |
| 2023-12-31 | 7.35% |
| 2023-09-30 | 13.71% |
| 2023-06-30 | 11.70% |
| 2023-03-31 | 9.83% |
| 2022-12-31 | 8.57% |
| 2022-09-30 | 7.94% |
| 2022-06-30 | 7.36% |
| 2022-03-31 | 6.83% |
| 2021-12-31 | 6.14% |
| 2021-09-30 | 4.72% |
| 2021-06-30 | 5.91% |
| 2021-03-31 | 5.49% |
| 2020-12-31 | 4.90% |
| 2020-09-30 | 14.48% |
| 2020-06-30 | 9.22% |
| 2019-12-31 | 9.78% |
